Macter International Limited (PSX:MACTER)
341.01
-0.23 (-0.07%)
At close: Dec 1, 2025
Macter International Market Cap
Macter International has a market cap or net worth of 15.52 billion as of December 2, 2025. Its market cap has increased by 105.48% in one year.
Market Cap
15.52B
Enterprise Value
16.10B
Revenue
10.96B
Ranking
n/a
PE Ratio
18.59
Stock Price
341.01
Market Cap Chart
Since September 25, 2017, Macter International's market cap has increased from 3.37B to 15.52B, an increase of 360.50%. That is a compound annual growth rate of 20.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 15.62B | 6.06% |
| Dec 31, 2024 | 14.73B | 265.38% |
| Dec 21, 2023 | 4.03B | -11.96% |
| Dec 28, 2022 | 4.58B | -9.14% |
| Dec 30, 2021 | 5.04B | -15.67% |
| Dec 31, 2020 | 5.98B | 80.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 127.21B |
| Abbott Laboratories (Pakistan) | 102.78B |
| The Searle Company | 60.70B |
| Highnoon Laboratories | 57.25B |
| AGP Limited | 52.45B |
| Shifa International Hospitals | 32.72B |
| Citi Pharma | 19.51B |
| Ferozsons Laboratories | 16.56B |